The Increasingly Vital Role of Early Alzheimer’s Disease Diagnosis & Treatment in Averting the Amyloid Tipping Point

Alzheimer’s disease (AD) is a growing public health concern, and as the aging population rapidly increases, so too does the number of individuals affected by AD. The recent availability of therapy for mild cognitive impairment (MCI) and early-stage AD has increased the need for early screening. In this uniquely designed, reflective activity, learners are presented with 2 cases related to AD and challenged to think about how the patients could have been better assessed/managed. A multidisciplinary discussion between a primary care physician (PCP) and neurologist will combine elements of cognitive assessment, proper screening and referral, and early management to demonstrate the critical relationship PCPs and neurologists have in identifying and managing patients with MCI/early-stage AD.